94 research outputs found
Towards an Effective Imaging-Based Decision Support System for Skin Cancer
The usage of expert systems to aid in medical decisions has been employed since 1980s in distinct ap plications. With the high demands of medical care and limited human resources, these technologies are
required more than ever. Skin cancer has been one of the pathologies with higher growth, which suf fers from lack of dermatology experts in most of the affected geographical areas. A permanent record
of examination that can be further analyzed are medical imaging modalities. Most of these modalities
were also assessed along with machine learning classification methods. It is the aim of this research to
provide background information about skin cancer types, medical imaging modalities, data mining and
machine learning methods, and their application on skin cancer imaging, as well as the disclosure of a
proposal of a multi-imaging modality decision support system for skin cancer diagnosis and treatment
assessment based in the most recent available technology. This is expected to be a reference for further
implementation of imaging-based clinical support systems.info:eu-repo/semantics/publishedVersio
Recommended from our members
Smartphone applications for triaging adults with skin lesions that are suspicious for melanoma
Background
Melanoma accounts for a small proportion of all skin cancer cases but is responsible for the majority of skin cancer-related
deaths. Early detection and treatment can improve survival. Smartphone applications are readily accessible and potentially
offer an instant risk assessment of the likelihood of malignancy, so that the right people seek further medical attention from a
clinician for more detailed assessment of the lesion. There is, however, a risk that melanomas will be missed and treatment
delayed if the application reassures the user that their lesion is low risk.
Objectives
To determine the diagnostic accuracy of smartphone applications to rule out cutaneous invasive melanoma and
intraepidermal melanocytic variants in adults with concerns about suspicious skin lesions.NIH
Exfoliative cytology for diagnosing basal cell carcinoma and other skin cancers in adults
Background: Early accurate detection of all skin cancer types is essential to guide appropriate management and to reduce morbidity and improve survival. Basal cell carcinoma (BCC) is usually localised to the skin with potential to infiltrate and damage surrounding tissue, while cutaneous squamous cell carcinoma (cSCC) and melanoma have a much higher potential to metastasise and ultimately lead to death. Exfoliative cytology is a non–invasive test that uses the Tzanck smear technique to identify disease by examining the structure of cells obtained from scraped samples. This simple procedure is a less invasive diagnostic test than a skin biopsy, and for BCC has the potential to provide an immediate diagnosis that avoids an additional visit to clinic to receive skin biopsy results. This may benefit patients scheduled for either Mohs micrographic surgery or non–surgical treatments such as radiotherapy. A cytology scrape can never give the same information as a skin biopsy, however, so it is important to know more about which skin cancer situations it may be helpful.Objectives: The primary objective was to determine the diagnostic accuracy of exfoliative cytology for the detection of basal cell carcinoma (BCC) in adults. Secondary objectives were to determine diagnostic accuracy for the detection of i) cutaneous squamous cell carcinoma, ii) invasive melanoma and atypical intraepidermal melanocytic variants, and iii) any skin cancer, including keratinocyte skin cancer, invasive melanoma and atypical intraepidermal melanocytic variants, or any other skin cancer.Search methods: We undertook a comprehensive search of the following databases from inception up to August 2016: Cochrane Central Register of Controlled Trials; MEDLINE; EMBASE; CINAHL; CPCI; Zetoc; Science Citation Index; US National Institutes of Health Ongoing Trials Register; NIHR Clinical Research Network Portfolio Database; and the World Health Organization International Clinical Trials Registry Platform. We also studied the reference lists of published systematic review articles.Selection criteria: Studies evaluating exfoliative cytology in adults with lesions suspicious for BCC, cSCC or melanoma, compared with a reference standard of histological confirmation.Data collection and analysis: Two review authors independently extracted all data using a standardised data extraction and quality assessment form (based on QUADAS-2). Where possible we estimated summary sensitivities and specificities using the bivariate hierarchical model.Main results: This review reports on nine studies with a total of 1655 lesions including 1120 BCCs (14 datasets), 401 lesions with 44 cSCCs (two datasets), and 200 lesions with 10 melanomas (one dataset). Three of these datasets (one each for BCC, melanoma, and any malignant condition) were derived from one study which also performed a direct comparison with dermoscopy. Studies were of moderate to poor quality providing inadequate descriptions of participant selection, thresholds used to make cytological and histological diagnoses, and blinding. Reporting of patients’ prior referral pathways was particularly poor, as were descriptions of the cytodiagnostic criteria used to make diagnoses. No studies evaluated the use of exfoliative cytology as a primary diagnostic test for detecting BCC or other skin cancers in lesions suspicious for skin cancer. Pooled data from seven studies using standard cytomorphological criteria (but various stain methods) to detect BCC in patients with a high clinical suspicion of BCC estimated the sensitivity and specificity of exfoliative cytology as 97.5% (95% CI: 94.5 to 98.9%) and 90.1% (95% CI: 81.1 to 95.1%) respectively. When applied to a hypothetical population of 1000 clinically suspected BCC lesions with a median observed BCC prevalence of 86%, exfoliative cytology would miss 21 BCCs and would lead to 14 false positive diagnoses of BCC. No false positive cases were histologically confirmed to be melanoma. Insufficient data are available to make summary statements regarding the accuracy of exfoliative cytology to detect melanoma or cSCC, or its accuracy compared to dermoscopy.Authors' conclusions: The utility of exfoliative cytology for the primary diagnosis of skin cancer is unknown, as all included studies focused on the use of this technique for confirming strongly suspected clinical diagnoses. For the confirmation of BCC in lesions with a high clinical suspicion, there is evidence of high sensitivity and specificity for exfoliative cytology. Since decisions to treat low riskBCCs are unlikely in practice to require diagnostic confirmation given that clinical suspicion is already high, exfoliative cytology might be most useful for cases of BCC where the treatments being contemplated require a tissue diagnosis (e.g. radiotherapy). The small number of included studies, poor reporting and varying methodological quality means that no strong conclusions can currently be drawn to guide clinical practice. Despite insufficient data on the use of cytology for cSCC or melanoma, it is unlikely that cytology would be useful in these scenarios since preservation of the architecture of the whole lesion that would be available from a biopsy provides crucial diagnostic information. Given the paucity of good quality data, appropriately designed prospective comparative studies may be required to evaluate both the diagnostic value of exfoliative cytology by comparison to dermoscopy, and its confirmatory value in adequately reported populations with a high probability of BCC scheduled for further treatment requiring a tissue diagnosis
The role of spectrophotometry in the diagnosis of melanoma
Background.
Spectrophotometry (SPT) could represent a promising technique for the diagnosis of cutaneous melanoma (CM) at earlier stages of the disease. Starting from our experience, we further assessed the role of SPT in CM early detection.
Methods.
During a health campaign for malignant melanoma at National Cancer Institute of Naples, we identified a subset of 54 lesions to be addressed to surgical excision and histological examination. Before surgery, all patients were investigated by clinical and epiluminescence microscopy (ELM) screenings; selected lesions underwent spectrophotometer analysis. For SPT, we used a video spectrophotometer imaging system (Spectroshade® MHT S.p.A., Verona, Italy).
Results.
Among the 54 patients harbouring cutaneous pigmented lesions, we performed comparison between results from the SPT screening and the histological diagnoses as well as evaluation of both sensitivity and specificity in detecting CM using either SPT or conventional approaches. For all pigmented lesions, agreement between histology and SPT classification was 57.4%. The sensitivity and specificity of SPT in detecting melanoma were 66.6% and 76.2%, respectively.
Conclusions.
Although SPT is still considered as a valuable diagnostic tool for CM, its low accuracy, sensitivity, and specificity represent the main hamper for the introduction of such a methodology in clinical practice. Dermoscopy remains the best diagnostic tool for the preoperative diagnosis of pigmented skin lesions
Systematic literature review of dermoscopic pigmented skin lesions classification using convolutional neural network (CNN)
The occurrence of pigmented skin lesions (PSL), including melanoma, are rising, and early detection is crucial for reducing mortality. To assist Pigmented skin lesions, including melanoma, are rising, and early detection is crucial in reducing mortality. To aid dermatologists in early detection, computational techniques have been developed. This research conducted a systematic literature review (SLR) to identify research goals, datasets, methodologies, and performance evaluation methods used in categorizing dermoscopic lesions. This review focuses on using convolutional neural networks (CNNs) in analyzing PSL. Based on specific inclusion and exclusion criteria, the review included 54 primary studies published on Scopus and PubMed between 2018 and 2022. The results showed that ResNet and self-developed CNN were used in 22% of the studies, followed by Ensemble at 20% and DenseNet at 9%. Public datasets such as ISIC 2019 were predominantly used, and 85% of the classifiers used were softmax. The findings suggest that the input, architecture, and output/feature modifications can enhance the model's performance, although improving sensitivity in multiclass classification remains a challenge. While there is no specific model approach to solve the problem in this area, we recommend simultaneously modifying the three clusters to improve the model's performance
Recommended from our members
The use of teledermatology for the diagnosis of skin cancer in adults
Background
Early accurate detection of all skin cancer types is essential to guide appropriate management and to improve morbidity and
survival. Melanoma and squamous cell carcinoma (SCC) are high risk skin cancers which have the potential to metastasise
and ultimately lead to death, whereas basal cell carcinoma (BCC) is usually localised with potential to infiltrate and damage
surrounding tissue. Anxiety around missing early curable cases needs to be balanced against inappropriate referral and
unnecessary excision of benign lesions. Teledermatology provides a way for generalist clinicians to access the opinion of a
specialist dermatologist for skin lesions that they consider to be suspicious without referring the patients concerned through
the normal referral pathway. Teledermatology consultations can be ‘store-and-forward’ with electronic digital images of a
lesion sent to a dermatologist for review at a later time, or can be live and interactive consultations using video conferencing
to connect the patient, referrer and dermatologist in real time.
Objectives
To determine the diagnostic accuracy of teledermatology for the detection of any skin cancer (melanoma, BCC or cSCC) inNIH
- …